[Therapeutic alternatives in benign prostatic hyperplasia].
Isa Kroon
W A
WA
Departamento de Urología, Facultad de Medicina, Universidad de Navarra, Pamplona.
Robles García
J E
JE
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D002404:Catheterization; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D011470:Prostatic Hyperplasia / Q000628:therapy*
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists